MIRA INFORM REPORT

 

 

Report Date :

15.06.2013

 

IDENTIFICATION DETAILS

 

Name :

ADVANCED VITAL ENZYMES LIMITED (w.e.f. 23.09.2008)

 

 

Formerly Known As :

ADVANCED BIO-NUTRACEUTICALS LIMITED

 

 

Registered Office :

5th Floor, 'A' wing, Sun Magnetica LIC Service Road, Louiswadi, Thane (West), Thane - 400 604

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

17.02.2005

 

 

Com. Reg. No.:

11-151389

 

 

Capital Investment / Paid-up Capital :

Rs.2.040 Millions

 

 

CIN No.:

[Company Identification No.]

U24230MH2005PLC151389

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Industrial Enzymes.

 

 

No. of Employees :

50 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ca (11)

 

RATING

STATUS

PROPOSED CREDIT LINE

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

 

Status :

Moderate

 

 

Payment Behaviour :

Slow and delayed

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having a moderate track record.

 

There appears huge accumulated losses as on 2012. External borrowings also appear to be huge. Networth has been fully eroded.

 

However, trade relations are fair. Business is active. Payment terms are reported as slow and delayed.

 

The company can be considered for business dealings with great caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (EMPLOYEE PROVIDENT FUND) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION PARTED BY (PARTIAL DETAILS)

 

Name :

Mr. Arun Kumar

Designation :

Export Department

Contact No.:

91-22-41703200

Date :

14.06.2013

 

 

LOCATIONS

 

Registered Office/ Corporate Office :

5th Floor, 'A' wing, Sun Magnetica LIC Service Road, Louiswadi, Thane (West), Thane - 400 604, India

Tel. No.:

91-22-41703200

Fax No.:

91-22-25835159

E-Mail :

info@enzymeindia.com

info@vitalenzymes.com

Website :

http://www.advancedenzymes.com

Location :

Owned

 

 

Factory :

Plot No.211, Phase – II, GIDC, Vapi – 396195, Gujarat, India

Area :

Owned

 

 

DIRECTORS

 

As on: 18.09.2012

 

Name :

Mr. Piyush Chandrakant Rathi

Designation :

Director

Address :

Row House No. 18, Teen hath Naka, Thane (West), Thane – 400601, Maharashtra, India

Date of Birth/Age :

28.07.1980

Date of Appointment :

17.02.2005

DIN No.:

00366347

 

 

Name :

Mr. Chandrakant Laxminarayan Rathi

Designation :

Director

Address :

Row House No. 18, Teen hath Naka, Thane (West), Thane – 400601, Maharashtra, India

Date of Birth/Age :

12.06.1954

Date of Appointment :

17.02.2005

DIN No.:

00365691

 

 

Name :

Ms. Savita Chandrakant Rathi

Designation :

Director

Address :

Row House No. 18, Teen hath Naka, Thane (West), Thane – 400601, Maharashtra, India

Date of Birth/Age :

26.02.1961

Date of Appointment :

17.02.2005

DIN No.:

00365717

 

 

Name :

Mr. Mukund Madhusudan Kabra

Designation :

Director

Address :

33, Sheetal Housing Society, Takli Road, Nasik – 422011, Maharashtra, India

Date of Birth/Age :

09.07.1972

Date of Appointment :

17.02.2005

DIN No.:

00148294

 

 

KEY EXECUTIVES

 

Name :

Mr. Arun Kumar

Designation :

Export Department

 

 

MAJOR SHAREHOLDERS

 

As on: 18.09.2012

 

Names of Shareholders

 

No. of Shares

Rathi L. Kishor on Behalf of Advanced Enzyme Technologies Limited

 

100

Rathi C. Piyush on Behalf of Advanced Enzyme Technologies Limited

 

18600

Rauka J. Beni on Behalf of Advanced Enzyme Technologies Limited

 

100

Rathi L. Chandrakant on Behalf of Advanced Enzyme Technologies Limited

 

100

Kabra M. Mukund on Behalf of Advanced Enzyme Technologies Limited

 

100

Rathi C. Savita on Behalf of Advanced Enzyme Technologies Limited

 

100

Chandrakant Rathi Finance and Investment Company Private Limited 

 

77600

Gitanjali Kabra

 

9400

Sri Ravishankar on Behalf of Sri Ravi Shankar Trust, India

 

9400

Atharva Captital Ventures Private Limited, India

 

48500

Natural Barter Private Limited

 

10000

Chandrakant Rathi HUF

 

15000

Piyush Chandrakant Rathi HUF

 

15000

Total

 

204000

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on: 18.09.2012

 

Category

Percentage

Bodies corporate

66.71

Directors or relatives of Directors

28.68

Other top fifty shareholders

4.61

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Industrial Enzymes.

 

 

Terms :

 

Selling :

Cash and Credit

 

 

Purchasing :

Cash and Credit

 

 

GENERAL INFORMATION

 

Customers :

End Users

 

 

No. of Employees :

50 (Approximately)

 

 

Bankers :

Not Available

 

 

Facilities :

(Rs. In Millions)

Secured Loan

As on

31.03.2012

As on

31.03.2011

LONG-TERM BORROWINGS

 

 

Hire Purchase finance from banks

0.400

0.559

Total

0.400

0.559

Unsecured Loan

As on

31.03.2012

As on

31.03.2011

LONG-TERM BORROWINGS

 

 

From a body corporate ( Shareholder)

57.395

69.185

Total

57.395

69.185

 

 

 

Banking Relations :

 

 

 

Auditors :

 

Name :

M.M. Nissim and Company

Chartered Accountants

Address :

Borodawala Mansion, B-Wing, 3rd Floor, 81, Dr. Annie Besant Road, Worli, Mumbai - 400018, Maharashtra, India

PAN No.:

AACPN0423A

 

 

CAPITAL STRUCTURE

 

As on: 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

500000

Equity Shares

Rs.10/- each

Rs.5.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

204000

Equity Shares

Rs.10/- each

Rs.2.040 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2012

31.03.2011

I.         EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

2.040

0.940

(a) Share Capital

 

0.000

0.000

(b) Reserves & Surplus

 

(26.893)

(35.255)

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

 

 

 

 

(3) Non-current liabilities

 

 

 

(a) long-term borrowings

 

57.795

69.744

(b) Deferred tax liabilities (Net)

 

0.573

0.984

(c) Other long term liabilities

 

0.000

0.000

(d) long-term provisions

 

0.000

0.000

 

 

 

 

(4) Current liabilities

 

 

 

(a) Short term borrowings

 

0.000

0.000

(b) Trade payables

 

16.678

20.963

(c) Other current liabilities

 

14.466

18.302

(d) Short-term provisions

 

0.272

0.000

TOTAL

 

64.931

75.678

 

 

 

 

II.     ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

46.017

47.930

(ii) Intangible Assets

 

0.000

0.000

(iii) Capital work-in-progress

 

0.000

0.000

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

0.000

0.000

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

0.000

0.500

(e) Other Non-current assets

 

0.766

0.784

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

6.194

10.621

(c) Trade receivables

 

10.307

7.088

(d) Cash and cash equivalents

 

0.297

0.578

(e) Short-term loans and advances

 

1.262

7.921

(f) Other current assets

 

0.088

0.256

TOTAL

 

64.931

75.678

 

 

SOURCES OF FUNDS

 

 

 

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

0.940

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

2.731

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

3.671

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

0.000

2] Unsecured Loans

 

 

49.385

TOTAL BORROWING

 

 

49.385

DEFERRED TAX LIABILITIES

 

 

0.604

 

 

 

 

TOTAL

 

 

53.660

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

50.146

Capital work-in-progress

 

 

0.000

 

 

 

 

INVESTMENT

 

 

0.000

DEFERREX TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

 

13.430

 

Sundry Debtors

 

 

8.209

 

Cash & Bank Balances

 

 

0.206

 

Other Current Assets

 

 

0.000

 

Loans & Advances

 

 

10.297

Total Current Assets

 

 

32.142

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

 

 

25.048

 

Other Current Liabilities

 

 

3.346

 

Provisions

 

 

0.234

Total Current Liabilities

 

 

28.628

Net Current Assets

 

 

3.514

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.000

 

 

 

 

TOTAL

 

 

53.660


 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Revenue from operations

63.956

58.275

28.866

 

 

Other Income

3.541

0.454

41.312

 

 

TOTAL                                     (A)

67.497

58.729

70.178

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of materials consumed

35.694

20.823

65.236

 

 

Changes in Inventory

(0.310)

4.893

 

 

 

Employee benefits expense

7.258

24.078

 

 

 

Other expenses

12.616

37.478

 

 

 

TOTAL                                     (B)

55.258

87.272

65.236

 

 

 

 

 

Less

PROFIT/ (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

12.239

(28.543)

4.942

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

7.669

5.326

0.027

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

4.570

(33.869)

4.915

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

3.400

3.737

3.108

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX (E-F)                  (G)

1.170

(37.606)

1.807

 

 

 

 

 

Less

TAX                                                                  (H)

(0.592)

0.380

0.869

 

 

 

 

 

 

PROFIT/ (LOSS) AFTER TAX (G-H)                   (I)

1.762

(37.986)

0.938

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

(37.015)

0.970

0.033

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

(35.253)

(37.015)

0.970

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Value of Import on CIF Basis

NA

NA

0.618

 

TOTAL IMPORTS

NA

NA

0.618

 

 

 

 

 

 

Earnings/ (Loss) Per Share (Rs.)

13.86

(404.11)

9.98

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

2.61

(64.68)

1.34

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

1.83

(64.53)

6.26

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

1.80

(49.69)

2.20

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

(0.05)

1.10

0.49

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

(2.33)

(2.03)

13.45

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.58

0.67

1.12

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

----------------------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

No

21]

Market information

----------------------

22]

Litigations that the firm / promoter involved in

----------------------

23]

Banking Details

No

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------------------

26]

Buyer visit details

----------------------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

REVIEW OF OPERATIONS:

 

During the year FY 2012 the Company has posted a revenue of Rs. 67.497 Millions as against Rs. 58.729 Millions in the previous year FY 2011. The net profit before tax of the Company is Rs. 1.170 Millions (1.73% of the revenue) during the year as against (Rs.37.985 Millions) of the previous year 2010-11.

 

 

FUTURE OUTLOOK:

 

Subject, (Advenza) is engaged in the business of development of proprietary products and does contract manufacturing of the said proprietary products for various companies of repute. The Company has long term contracts. Henceforth the Company will continue to focus on the development of its own proprietary products, licensing for the same and contract manufacturing of those products. The strategic objective of this move was to establish the Company as a leader in contract manufacturing of stabilized enzymes and nutraceutical (food grade) preparations across India. Your Company will also manufacture non-enzyme preparations on a profitable basis if the capacities permit.

 

 

FIXED ASSETS:

 

·         Leasehold Land

·         Buildings

·         Plant and Machinery

·         Office Equipments

·         Furniture and Fixtures

·         Computer

·         Vehicles

 

 

AS PER WEBSITE DETAILS:

 

PRESS RELEASE:

 

ADVANCED ENZYMES TECHNOLOGIES OPENS PLANT IN INDORE

 

Our News Bureau - Mumbai

 

Advanced Enzymes, manufacturer of industrial enzymes, has set up an ultra-modern manufacturing facility near Indore. The state-of-the-art plant has been built with an investment of over Rs 600.000 Millions and incorporates the topmost technological innovations available in the enzyme industry globally.

 

The new plant, spread over 38400 sq. mt, has the potential of providing employment to over 100 people, directly or indirectly. The new plant has enabled Advanced Enzymes to treble its fermentation capacity from 120 cu mt to 400 cu mt. The facility is also indigenously designed in such a way, that a further fermentation capacity of 600 cu mt can be added up in the same plant with minimal incremental investment in the near future.

 

C L Rathi, Managing Director, Advanced Enzymes said, “The new facility will help us cater to various industries and increase our global foot print. With the new plant in place, Advanced Enzymes expects to meet the growing demand for its products globally. As such 65 per cent of its total revenues are already generated from its international operations and this figure is expected to grow still higher in the near future.”

 

 

ADVANCED ENZYME TECHNOLOGIES FILES DRHP WITH SEBI

 

4 April, 2013

 

Advanced Enzyme Technologies has filed a draft red herring prospectus (DRHP) with SEBI for a public issue of Rs 2000.000 Millions. 

 

The company is one of the largest Indian enzyme company engaged in the research & development, manufacturing and marketing of more than 400 proprietary enzyme products developed from 55 enzymes operating in two primary business verticals namely Healthcare & Nutrition and Bio-Processing. Advanced Enzyme Technologies offer these products to their global clientele of more than 700 customers spanning presence across 45 countries worldwide.

 

The main objects of this issue are: 

 

> Phase-III expansion of the Manufacturing facility at Indore


> Establishment of Research and Development Centre at Nashik


> Establishment of Research & Development and Innovation Centre at Thane


> Investment in our step-down subsidiary (Cal India Foods International) for setup of manufacturing and R&D facilities
> Acquisitions & Other Strategic Initiatives and

 

> General Corporate Purposes 

 

The Equity Shares issued through this DRHP are proposed to be listed on BSE and NSE. 

ICICI Securities Limited, SBI Capital Markets Limited are the book running lead manager and Link In time India Private Limited is a registrar to the issue.

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.57.74

UK Pound

1

Rs.90.64

Euro

1

Rs.77.02

 

 

INFORMATION DETAILS

 

Information Gathered by :

SVA

 

 

Report Prepared by :

RAJ

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

2

PAID-UP CAPITAL

1~10

1

OPERATING SCALE

1~10

1

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

2

--PROFITABILIRY

1~10

1

--LIQUIDITY

1~10

1

--LEVERAGE

1~10

1

--RESERVES

1~10

1

--CREDIT LINES

1~10

1

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

11

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.